- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Anonymous GP alleged an AstraZeneca rep offered savings via his private consumables company, creating a perceived inducement/conflict. Panel had concerns about perception…
A Cipralex (escitalopram) journal ad said “For references and prescribing information, see overleaf” in text smaller than the Code’s 2mm requirement and…
Alcon’s Azarga leavepiece repeatedly used “comfort/comfortable”. Appeal Board allowed the comparative “Significantly more comfortable than Cosopt” claim (with data), but upheld breaches…
Anonymous key account manager alleged verbal contact-rate targets forced Code breaches. Panel found no evidence targets required excessive calls; company data suggested…
Three complaints about a 2004 Seroquel journal ad. PMCPA ruled the “only atypical… favourable weight profile across the full dose range” claim…
A British Pain Society poster/handout about Versatis included an “off-label” cost-saving conclusion. PMCPA ruled the poster was promotional, breached off-label and high-standards…
PMCPA ruled Pfizer in breach after two regional account directors had been in post for 2 years without passing the ABPI Medical…
PMCPA case summary: Anonymous non-contactable complainant vs PharmaMar (AUTH/2979/9/17). Case details, clauses, outcome and sanctions were not stated in the provided case…
A GP complained a Novartis-sponsored Entresto presentation was unbalanced and omitted side effects. The PMCPA Panel found the overall meeting included safety/SPC…
AstraZeneca’s HCP website content for Onglyza and Symbicort COPD was ruled misleading due to layout/undue emphasis on relative effects. Forxiga and Symbicort…
A health professional alleged Otsuka’s Jinarc training portal was promotional, lacked compliant prescribing info and improperly referenced the MHRA. The Panel found…
Allergan’s tender-related presentation reused Hunt & Clarke animal assay data in a way that implied Botox was more potent than Xeomin, contrary…
A two-page Amias ad compared ARBs in heart failure and marked losartan as a black triangle drug. PMCPA held this implied all…
Patients attended and spoke at a Sanofi-Aventis promotional meeting where Multaq was promoted, leading to a breach for advertising a POM to…
A doctor complained a Pradaxa promotional email was sent to his NHS account and had no unsubscribe link. Panel found consent likely…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.